PTX 1.89% 5.2¢ prescient therapeutics limited

Ann: June 2019 Appendix 4C - Quarterly, page-2

  1. 689 Posts.
    lightbulb Created with Sketch. 267
    Below is obviously the most interesting part of the announcement - even though it is so ambiguous. The question is though does that mean they're looking at further acquisitions, partnering in combination therapy trials or (more hopefully) out-licensing? Either way, you'd have to imagine something is definitely happening behind the scenes. I guess we'll know in the next few months.

    "With interest in potential for targeted and personalized cancer therapies gaining momentum, Prescient continued to actively review several potential strategic partnership initiatives that would expand and advance our therapeutic pipeline and enhance shareholder value."
    Last edited by megamutts: 24/07/19
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
-0.001(1.89%)
Mkt cap ! $41.87M
Open High Low Value Volume
5.6¢ 5.6¢ 5.2¢ $10.74K 201.6K

Buyers (Bids)

No. Vol. Price($)
2 137796 5.2¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 49975 1
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
5.2¢
  Change
-0.001 ( 1.89 %)
Open High Low Volume
5.5¢ 5.5¢ 5.2¢ 118131
Last updated 15.30pm 19/03/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.